Natalya Griko

Senior Scientist at Ayass BioScience, LLC

Natalia Griko has extensive experience in molecular biology, currently serving as a Senior Scientist and Molecular Biology Scientist at Ayass BioScience since December 2015. Prior to this, Natalia held the position of Senior Research Scientist at Texas A&M University Baylor College of Dentistry from September 2014 to November 2015 and at CustomGene, LLC from July 2012 to August 2014. Additionally, Natalia served as a Senior Research Scientist at Biological Targets Inc from January 2007 to July 2012 and worked as a Research Scientist at the University of Texas at Dallas from 1999 to 2007. Educationally, Natalia earned a Doctor of Philosophy (Ph.D.) in Molecular Biology from the Institute of Protein Research at the Russian Academy of Sciences in Pushchino, Moscow region, Russia.

Location

Dallas, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Ayass BioScience, LLC

Ayass BioScience, LLC was established in 2014 with a mission to provide early disease detection, develop a disease monitoring system, and ultimately achieve better patient outcome by implementing Molecular Modern Medicine to daily clinical practice. We emphasize on Pathophysiology, Genetic, Epigenetic, and Proteomic/Metabolic profiling by conducting comprehensive immunologic testing, and next generation sequencing. Data collection and, more importantly, data interpretation through our bioinformatics and biostatistics department provides meaningful molecular analysis that guides precision medical practices. Our research in the field of Aptamers has opened the door to ground-breaking technology in the fields of both diagnostics and therapeutics. Our goal is to help clinicians implement unique precision medicine in their daily practice. Ayass BioScience, LLC (DBA as Ayass Lung Clinic, PLLC) is a CLIA certified laboratory performing advanced Next Generation Sequencing (Genetic Testing), Cardiac Conditions Hereditary Risk Assessment, Hereditary Cancer Risk Assessment, Neurological Conditions Genetic Predisposition Testing, also COVID-19 Testing (COVID-19 SARS-CoV-2 by RT-PCR), Pharmacogenetic Testing, Allergen Component-Resolved Testing, and Innovative Laboratory Testing. Ayass BioiScience, LLC is working on Aptamers Research and Testing. Ayass BioScience, LLC aims to be at the forefront of latest advancements in precision medicine to provide you with the most effective prevention and treatment options possible.


Employees

11-50

Links